New oral migraine drug, Amerge

March 1998

    Glaxo is introducing their new oral migraine drug, Amerge.

    Think of Amerge (naratriptan) as similar to oral Imitrex (sumatriptan)...except Amerge is longer-acting.

    This means fewer recurrent headaches with Amerge than with Imitrex. About 40% of patients using Imitrex have recurrent headaches because of its short half-life.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote